• Clinical Trials - Non-Hodgkin's Lymphoma

    Study Objective Contact
    An Open-Label, Randomized, Phase 2 Study to Assess The Effectiveness Of RCHOP With Or Without VELCADE In Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma [LCID Study Number: 2010-062] There are two main categories of DLBCL- 1) germinal center (GC) type and 2) non-GC type. The standard treatment for both types of DLBCL is a combination of drugs called RCHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Unfortunately, RCHOP works less well in patients with non-GC DLBCL. However, a better treatment than RCHOP for patients with non-GC DLBCL is not currently known. Principal Investigator(s):
    Tarun Kewalramani, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Deborah J. Gannon,
    Nancy M. Campbell, RN.